Assessing microbial risk to patients from aseptically manufactured pharmaceuticals

Whyte, W. (2004) Assessing microbial risk to patients from aseptically manufactured pharmaceuticals. European Journal of Parenteral and Pharmaceutical Sciences, 9(3), pp. 71-77.

[img]
Preview
Text
86267.pdf - Published Version

106kB

Abstract

The microbial risk to patients from aseptically manufactured pharmaceuticals is dependent on the chance that a product contains sufficient microbes to initiate an infection. This possibility is dependent on risk factors associated with the method of production and product formulation, and can be calculated. An analysis of these risk factors can be used to minimise patient risk and assist in determining the appropriate level of contamination control required for manufacturing.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Whyte, Dr William
Authors: Whyte, W.
College/School:College of Science and Engineering
Journal Name:European Journal of Parenteral and Pharmaceutical Sciences
Publisher:Euromed Communications Ltd.
ISSN:0964-4679
ISSN (Online):1740-6277
Copyright Holders:Copyright © 2004 The Pharmaceutical and Healthcare Sciences Society
First Published:First published in European Journal of Parenteral and Pharmaceutical Sciences 9(3):71-77
Publisher Policy:Reproduced in accordance with the permission of the publisher.

University Staff: Request a correction | Enlighten Editors: Update this record